{
  "name": "Johnson & Johnson",
  "slug": "johnson-and-johnson",
  "ticker": "JNJ",
  "fetched_at": "2025-09-01T12:22:51.502823+00:00",
  "news": [
    {
      "title": "After trial failure, J&J ditches Imaavy as combo agent for rheumatoid arthritis - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOdnFneUJsekdSN3RyMlFkdnhXNFpIbEJtTWJLMEgzLTFWODFHT2JFcmhaUmV5ZXYyRERfUWdwcW54TW1fNWhFT2RWVkN0N1kxbFltdUN3aENFTEFlSXFzeVdYSTVRN3ZNWUlVLTdBdDIzT3BFX21MZ0ZRdnRyMXpZMlBkQ203YXg2aWhyalVMdEQyVEJWcjJ0Z2wtTzljZXJKbzFQYlVtdw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipwFBVV95cUxOdnFneUJsekdSN3RyMlFkdnhXNFpIbEJtTWJLMEgzLTFWODFHT2JFcmhaUmV5ZXYyRERfUWdwcW54TW1fNWhFT2RWVkN0N1kxbFltdUN3aENFTEFlSXFzeVdYSTVRN3ZNWUlVLTdBdDIzT3BFX21MZ0ZRdnRyMXpZMlBkQ203YXg2aWhyalVMdEQyVEJWcjJ0Z2wtTzljZXJKbzFQYlVtdw?oc=5\" target=\"_blank\">After trial failure, J&amp;J ditches Imaavy as combo agent for rheumatoid arthritis</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-08-29T14:56:45+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Judge deals Johnson & Johnson $442M catheter suit blow with denied motion, injunction - MassDevice",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxOQlFSRUJMaFU4NXhrMVpLZU5seThxMDR3aFFvWnVXZXpWOHRXYmhzdXZ5NkgwaE5vRGpPQ2UyWjI5N29vdk1OTlNZS0VEVVNHd1REWk5zLW5Ec0xtRGRILXVzSzQ3OUhzVVA0d1RxeS1FTEFXaDZ5c2JoYzJWZzdfTER6SGQ1QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxOQlFSRUJMaFU4NXhrMVpLZU5seThxMDR3aFFvWnVXZXpWOHRXYmhzdXZ5NkgwaE5vRGpPQ2UyWjI5N29vdk1OTlNZS0VEVVNHd1REWk5zLW5Ec0xtRGRILXVzSzQ3OUhzVVA0d1RxeS1FTEFXaDZ5c2JoYzJWZzdfTER6SGQ1QQ?oc=5\" target=\"_blank\">Judge deals Johnson & Johnson $442M catheter suit blow with denied motion, injunction</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MassDevice</font>",
      "published": "2025-08-29T07:00:00+00:00",
      "source": "MassDevice"
    },
    {
      "title": "How Is Johnson & Johnson’s Stock Performance Compared to Other Healthcare Stocks? - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMikgFBVV95cUxOSGQ2VGJCcG1pb01wOWVsRUZfSjlJQ24ycTZZaWJNQjBSRnU0Q21WQnFpNUw5Nkotc2wwN0xjdGpRc2lWaFpkOFZOQlpYeDZUdWxkd2tSZ0FiWTJoREpQdFdmWlpvUGZEMlFnZlBRV2t4QndEWi0wUHR4WUplb1MtZnpoT294NzNvaTZWdUZMSjItdw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikgFBVV95cUxOSGQ2VGJCcG1pb01wOWVsRUZfSjlJQ24ycTZZaWJNQjBSRnU0Q21WQnFpNUw5Nkotc2wwN0xjdGpRc2lWaFpkOFZOQlpYeDZUdWxkd2tSZ0FiWTJoREpQdFdmWlpvUGZEMlFnZlBRV2t4QndEWi0wUHR4WUplb1MtZnpoT294NzNvaTZWdUZMSjItdw?oc=5\" target=\"_blank\">How Is Johnson & Johnson’s Stock Performance Compared to Other Healthcare Stocks?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-29T10:48:13+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "J&J halts studies for potential rival to AbbVie’s Humira after trial setback - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPak92al9kODZWWXZkbm05bi1CTnJBM09uQWd0U3RVbkFMTTh6YkxVZUpGS1kzVFU1Zk1hZzV6djcwMlVpVEVpdzVRTk5JbEt4a2MySENReS1iS2lyMU0wb1gyaVBMcmpSX2VrdWtJY1dlaXlvb3VRclBIRmlUbHNrc0RVM0lLUXM?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihwFBVV95cUxPak92al9kODZWWXZkbm05bi1CTnJBM09uQWd0U3RVbkFMTTh6YkxVZUpGS1kzVFU1Zk1hZzV6djcwMlVpVEVpdzVRTk5JbEt4a2MySENReS1iS2lyMU0wb1gyaVBMcmpSX2VrdWtJY1dlaXlvb3VRclBIRmlUbHNrc0RVM0lLUXM?oc=5\" target=\"_blank\">J&amp;J halts studies for potential rival to AbbVie’s Humira after trial setback</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-08-29T11:05:39+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "J&J Ends Rheumatoid Arthritis Program After Disappointing Mid-Stage Data - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOcTNxb2l4Q1R5QUFkcHBzNlpqLWg2Z3k1RVFtaTA2amxYbF9RM3Fza0Mxd21YelBTRGh2emdnSlI3NkFHWGpqMUUzMFNsTWl5WHlnUHlGaWs2WmkzMThLTnZGcFVxakFON1JPcm02aTdZTjVyMjNnXzJyc0EzOWNhOWNldWpvTmpkSGZvWFBQVVNQdUM3Z1pLdm9GcEhvSEo0anRRTkJlVUktd1pHakhZakE3ano?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMitAFBVV95cUxOcTNxb2l4Q1R5QUFkcHBzNlpqLWg2Z3k1RVFtaTA2amxYbF9RM3Fza0Mxd21YelBTRGh2emdnSlI3NkFHWGpqMUUzMFNsTWl5WHlnUHlGaWs2WmkzMThLTnZGcFVxakFON1JPcm02aTdZTjVyMjNnXzJyc0EzOWNhOWNldWpvTmpkSGZvWFBQVVNQdUM3Z1pLdm9GcEhvSEo0anRRTkJlVUktd1pHakhZakE3ano?oc=5\" target=\"_blank\">J&amp;J Ends Rheumatoid Arthritis Program After Disappointing Mid-Stage Data</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-08-29T12:27:01+00:00",
      "source": "BioSpace"
    },
    {
      "title": "J&J scraps Imaavy combo with anti-TNFα in rheumatoid arthritis after mid-stage flop - FirstWord Pharma",
      "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5aRXhkNmpyZnk1VUVMN3dwUFJDT0dseWt3U3hrQ3ZnOFV1UWdtOFJXcV84VTEtUVJuanlHRU5EQ2g3TGh3YkVaX3hQal9GVy00dmM0?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5aRXhkNmpyZnk1VUVMN3dwUFJDT0dseWt3U3hrQ3ZnOFV1UWdtOFJXcV84VTEtUVJuanlHRU5EQ2g3TGh3YkVaX3hQal9GVy00dmM0?oc=5\" target=\"_blank\">J&amp;J scraps Imaavy combo with anti-TNFα in rheumatoid arthritis after mid-stage flop</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">FirstWord Pharma</font>",
      "published": "2025-08-29T06:13:42+00:00",
      "source": "FirstWord Pharma"
    },
    {
      "title": "Johnson & Johnson to invest $2B in North Carolina plant as Trump’s 250% drug tariffs loom - New York Post",
      "link": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQME1MM0FoQndYd2lqcTZKdXRVbHpZVjVZMG1kS0pHT0NieVd5QWE1Uk1OU0FUSFI1UThFTVhPRHQ2QlZyVjVzcnNmOEpaODZQZ0JsWVJlNFhLYVNlSUZKaWpwR3JJcVJYR0xxSW95amlUNWJhWEg0akpGNVhGNDRJeU1MeWl3aE81bVVOQWJhSkxaOEVYcFdHLVN2akY?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMinAFBVV95cUxQME1MM0FoQndYd2lqcTZKdXRVbHpZVjVZMG1kS0pHT0NieVd5QWE1Uk1OU0FUSFI1UThFTVhPRHQ2QlZyVjVzcnNmOEpaODZQZ0JsWVJlNFhLYVNlSUZKaWpwR3JJcVJYR0xxSW95amlUNWJhWEg0akpGNVhGNDRJeU1MeWl3aE81bVVOQWJhSkxaOEVYcFdHLVN2akY?oc=5\" target=\"_blank\">Johnson & Johnson to invest $2B in North Carolina plant as Trump’s 250% drug tariffs loom</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">New York Post</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "New York Post"
    },
    {
      "title": "J&J to invest $2 billion to boost US manufacturing as drug tariffs loom - Reuters",
      "link": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQSGMwMVhvc0hFRzVfYmFGdlE2dkVIZWRLWmFpcVpJYXdaME01bHFHdHpCVnJCTzVzYTNRaFp3T1ZhTF9QVDQwN0J4cTNJcFRJeVVxT0lRbXhiLWsycnMxQk0wZVR1bFlHa1JoZmdON2luNk1DWklCanEtUzh5QkFubFVtaGtrRnRrdC1PRW5kdERfTTVuLVV6bi1KQmRyaVoyS1hoMmlNWEpGSkU4WkdnazlMTVRaNzRWQnNfX05QWV9tSDNPRThfNUM3NEM?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMizAFBVV95cUxQSGMwMVhvc0hFRzVfYmFGdlE2dkVIZWRLWmFpcVpJYXdaME01bHFHdHpCVnJCTzVzYTNRaFp3T1ZhTF9QVDQwN0J4cTNJcFRJeVVxT0lRbXhiLWsycnMxQk0wZVR1bFlHa1JoZmdON2luNk1DWklCanEtUzh5QkFubFVtaGtrRnRrdC1PRW5kdERfTTVuLVV6bi1KQmRyaVoyS1hoMmlNWEpGSkU4WkdnazlMTVRaNzRWQnNfX05QWV9tSDNPRThfNUM3NEM?oc=5\" target=\"_blank\">J&amp;J to invest $2 billion to boost US manufacturing as drug tariffs loom</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-21T07:00:00+00:00",
      "source": "Reuters"
    }
  ],
  "product_launches": [
    {
      "title": "Johnson & Johnson Launches VIRTUGUIDE™ AI-Powered Patient-Matched Lapidus System in U.S. to Reduce Complexity in Bunion Surgery for Millions - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMinAJBVV95cUxNVTk1X25qaHJuQURPZktUYmJQQ3pLTlZqaHJRWjdjcVBfRnRaUVB1UnROekN4aU14ek5DQW5oOW51dmt1M0hTR2tXMG9hMDlzeEVscDNfVWs1cmF4eXlkY1BtVzM0NGtjZVNnSmxwX3Z3X2FHc0haZVJaM1lHWmlwMEpnVkxIalI4LUZ1alNyUlp6emY5b1NCV214WVlBam01QjFNQlFYeTZWOFZLVmpHOFN5LTFsQlVETVZXQWRiVEhZWUdiaFJ6SFNqSTBuMEZKTWptRE5zNUJLNVc4TjFXZWI4WlVOT2hTc1BvZE51S1NmRzR6RHd1YUNkQThwRlJfS0hIcER5dURkYUlOQ1FnTW5fMmVDUUFiSmlYcA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMinAJBVV95cUxNVTk1X25qaHJuQURPZktUYmJQQ3pLTlZqaHJRWjdjcVBfRnRaUVB1UnROekN4aU14ek5DQW5oOW51dmt1M0hTR2tXMG9hMDlzeEVscDNfVWs1cmF4eXlkY1BtVzM0NGtjZVNnSmxwX3Z3X2FHc0haZVJaM1lHWmlwMEpnVkxIalI4LUZ1alNyUlp6emY5b1NCV214WVlBam01QjFNQlFYeTZWOFZLVmpHOFN5LTFsQlVETVZXQWRiVEhZWUdiaFJ6SFNqSTBuMEZKTWptRE5zNUJLNVc4TjFXZWI4WlVOT2hTc1BvZE51S1NmRzR6RHd1YUNkQThwRlJfS0hIcER5dURkYUlOQ1FnTW5fMmVDUUFiSmlYcA?oc=5\" target=\"_blank\">Johnson & Johnson Launches VIRTUGUIDE™ AI-Powered Patient-Matched Lapidus System in U.S. to Reduce Complexity in Bunion Surgery for Millions</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2025-07-29T07:00:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "How a Legal Setback and MedTech Advances Could Shape Johnson & Johnson’s (JNJ) Outlook - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">How a Legal Setback and MedTech Advances Could Shape Johnson & Johnson’s (JNJ) Outlook</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-08-11T07:00:00+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Johnson & Johnson MedTech resumes Varipulse sales after stroke-related pause - MassDevice",
      "link": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPY1FqOVZJWENMVkdhNkUtWlo0NHNrXzRHVW03Uzg0NHpJOUhYWXozRWUyTEd0U0dFUFlVM1FiNzFDWEJMZGlvNEphaXE3ZXpqUmVPa0lFd3JUQ3ZiZFBadUZObktPU29tWnp2ZGs3WExXbVlIWU9DMGpzQTVBLS1aVw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMigAFBVV95cUxPY1FqOVZJWENMVkdhNkUtWlo0NHNrXzRHVW03Uzg0NHpJOUhYWXozRWUyTEd0U0dFUFlVM1FiNzFDWEJMZGlvNEphaXE3ZXpqUmVPa0lFd3JUQ3ZiZFBadUZObktPU29tWnp2ZGs3WExXbVlIWU9DMGpzQTVBLS1aVw?oc=5\" target=\"_blank\">Johnson & Johnson MedTech resumes Varipulse sales after stroke-related pause</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MassDevice</font>",
      "published": "2025-02-28T08:00:00+00:00",
      "source": "MassDevice"
    },
    {
      "title": "Johnson & Johnson Reports Q2 2025 Results; Raises 2025 Outlook - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOd1RGbnFKZnZpWFQ5ZFctcm13TnJuTVZUYkFKQzRfXzlsSDJJSWtkNy1pdUtiVTBrYWZESm9JeEJsWVJJNFhXR0Rpa1hMLWNPSWU4dnRyTFc0S1JVcllJd2lJX0hVUHI0MzRWR19rZmdxZ3dwMEFpSHBMc0NCSmIxTkx1eVc1OWQ1YmYxZzc2bE1jcndJb1F0MktHeXBkQ1ZW?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMioAFBVV95cUxOd1RGbnFKZnZpWFQ5ZFctcm13TnJuTVZUYkFKQzRfXzlsSDJJSWtkNy1pdUtiVTBrYWZESm9JeEJsWVJJNFhXR0Rpa1hMLWNPSWU4dnRyTFc0S1JVcllJd2lJX0hVUHI0MzRWR19rZmdxZ3dwMEFpSHBMc0NCSmIxTkx1eVc1OWQ1YmYxZzc2bE1jcndJb1F0MktHeXBkQ1ZW?oc=5\" target=\"_blank\">Johnson & Johnson Reports Q2 2025 Results; Raises 2025 Outlook</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-07-16T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Johnson & Johnson boosts financial projections with growing cardiac device sales - Fierce Biotech",
      "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNczRUSWVqRlFPUFl0UjM3TTdrNm51Q21wUkVGaVFmNkhGVVh1VGRCZHJ6Q0hFeWJKSTI2bFphLWJMa1d2VTNaYTI4NUV6T3VFSFNGSFVGVzJaX20tV0pEdEpwWHNfWTRnNGxBTEg3NmFONkQ2R1QyUkJJWFBMSnFGQlVYeGVYRUdWd25aZzZCb1B4UXpjaHBnWTRablhkcjJiT25nNzF3Sk1SQjF1V1VQTw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisAFBVV95cUxNczRUSWVqRlFPUFl0UjM3TTdrNm51Q21wUkVGaVFmNkhGVVh1VGRCZHJ6Q0hFeWJKSTI2bFphLWJMa1d2VTNaYTI4NUV6T3VFSFNGSFVGVzJaX20tV0pEdEpwWHNfWTRnNGxBTEg3NmFONkQ2R1QyUkJJWFBMSnFGQlVYeGVYRUdWd25aZzZCb1B4UXpjaHBnWTRablhkcjJiT25nNzF3Sk1SQjF1V1VQTw?oc=5\" target=\"_blank\">Johnson & Johnson boosts financial projections with growing cardiac device sales</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Biotech</font>",
      "published": "2025-07-16T07:00:00+00:00",
      "source": "Fierce Biotech"
    }
  ],
  "stock": {
    "ticker": "JNJ",
    "currency": "USD",
    "latest": {
      "date": "2025-08-29",
      "close": 177.1699981689453
    },
    "history": [
      {
        "date": "2025-08-21",
        "close": 177.62620544433594
      },
      {
        "date": "2025-08-22",
        "close": 177.98358154296875
      },
      {
        "date": "2025-08-25",
        "close": 177.11000061035156
      },
      {
        "date": "2025-08-26",
        "close": 176.49000549316406
      },
      {
        "date": "2025-08-27",
        "close": 176.7899932861328
      },
      {
        "date": "2025-08-28",
        "close": 175.4499969482422
      },
      {
        "date": "2025-08-29",
        "close": 177.1699981689453
      }
    ],
    "name": "Johnson & Johnson"
  }
}